Pharmacology of Restless Legs Syndrome (RLS)
Specificaties
Gebonden, blz.
|
Engels
Elsevier Science |
2019
ISBN13: 9780128167588
Rubricering
Onderdeel van serie
Advances in Pharmacology
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Pharmacology of Restless Legs Syndrome (RLS), Volume 84, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field on essential topics, with this volume presenting chapters on Targeting the adenosinergic system in Restless Legs Syndrome, Assessing iron uptake mechanisms in the brain: impact of gender and genotype, Pharmacological treatments of RLS in augmentation, C. elegans and its applicability to studies on RLS, The neurophysiology of hyperarousal in RLS: hints for a role of glutamate/GABA, Treatment management and options in RLS patients, Pharmacological responsiveness of Periodic Legs Movements during Sleep, and more.
Specificaties
ISBN13:9780128167588
Taal:Engels
Bindwijze:Gebonden
Uitgever:Elsevier Science
Serie:Advances in Pharmacology
Inhoudsopgave
<p>1. Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport<br>Sergi Ferré, César Quiroz, William Rea, Xavier Guitart and Diego García-Borreguero<br>2. D3 receptor agonist efficacy in restless legs syndrome<br>Francesca Casoni, Andrea Galbiati and Luigi Ferini-Strambi<br>3. The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome<br>Antoni Cortés, Verònica Casadó-Anguera, Estefanía Moreno and Vicent Casadó<br>4. D3 and D1 receptors: The Yin and Yang in the treatment of restless legs syndrome with dopaminergics<br>Stefan Clemens and Imad Ghorayeb<br>5. The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate/GABA<br>Giuseppe Lanza and Raffale Ferri<br>6. Iron uptake at the blood-brain barrier is influenced by sex and genotype<br>Quinn W. Wade, Brian Chiou and James R. Connor<br>7. Caenorhabditis elegans and its applicability to studies on restless legs syndrome<br>Pan Chen, Omamuyovwi Meashack Ijomone, Kun He Lee and Michael Aschner<br>8. Role of MEIS1 in restless legs syndrome: From GWAS to functional studies in mice<br>Aaro V. Salminen, Daniel D. Lam and Juliane Winkelmann<br>9. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome<br>Vivian Wanner, Celia Garcia Malo, Sofía Romero, Irene Cano-Pumarega and Diego García-Borreguero<br>10. Idiopathic restless legs syndrome treatment: Progress and pitfalls?<br>Imad Ghorayeb<br>11. Treatment of pediatric restless legs syndrome<br>Lourdes DelRosso and Oliviero Bruni<br>12. Pharmacological treatments of augmentation in restless legs syndrome patients<br>Claudia Trenkwalder and Walter Paulus</p>